EGM
KYMR icon

Engineers Gate Manager’s Kymera Therapeutics KYMR Stock Holding History

Engineers Gate Manager’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,475
Closed -$366K – 2329
2025
Q3 		$366K Buy
+6,475
New +$292K ﹤0.01% 1652
2024
Q2 		– Sell
-20,994
Closed -$844K – 2104
2024
Q1 		$844K Sell
20,994
-4,129
-16% -$148K 0.02% 924
2023
Q4 		$640K Buy
+25,123
New +$449K 0.02% 1045
2022
Q4 		– Sell
-10,921
Closed -$238K – 1871
2022
Q3 		$238K Buy
+10,921
New +$288K 0.01% 1227

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Engineers Gate Manager's KYMR Position: Q4 2025 in Review

Engineers Gate Manager sold out of Kymera Therapeutics (KYMR) in Q4 2025, closing a stake of 6,475 shares — an estimated $366K sold.

Engineers Gate Manager first reported a position in KYMR in Q3 2022 and held it in 4 quarters. The position peaked at $844K in Q1 2024. 254 funds tracked by Wall St. Rank hold KYMR as of Q4 2025.

  • Engineers Gate Manager reported no remaining Kymera Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 6,475 Kymera Therapeutics shares in Q4 2025, an estimated $366K.
  • Engineers Gate Manager first reported a position in Kymera Therapeutics in Q3 2022 and held it in 4 quarters.
  • Engineers Gate Manager's Kymera Therapeutics position peaked at $844K in Q1 2024.
  • 254 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q4 2025.

Based on Engineers Gate Manager's 13F filing for Q4 2025, filed 17 Feb 2026.